000218217 000__ 01555cam\a2200349Ia\45e0
000218217 001__ 218217
000218217 005__ 20220217104115.0
000218217 008__ 990623s1998\\\\dcu\\\\\\\\\\f000\0\eng\d
000218217 020__ $$a0160578973
000218217 035__ $$a(OCoLC)40709390
000218217 035__ $$a218217
000218217 040__ $$aGPO$$cGPO$$dOCL$$dGUL$$dISE
000218217 043__ $$an-us---
000218217 049__ $$aISEA
000218217 074__ $$a1019-A-01
000218217 074__ $$a1019-B-01 (MF)
000218217 0860_ $$aY 4.C 73/8:105-W
000218217 088__ $$aCommittee print 105-W (United States. Congress. House. Committee on Commerce)
000218217 090__ $$aKF3871$$b.A25 1998
000218217 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Commerce.$$bSubcommittee on Oversight and Investigations.
000218217 24510 $$aWithout reasonable assurance, financial and property management concerns at the Food and Drug Administration :$$ba staff report /$$cprepared for the use of the Subcommittee on Oversight and Investigations of the Committee on Commerce, U.S. House of Representatives.
000218217 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1998.
000218217 300__ $$aiv, 46 p. ;$$c24 cm.
000218217 500__ $$aAt head of title: 105th Congress, 2d session. Committee print.
000218217 500__ $$aDistributed to some depository libraries in microfiche.
000218217 500__ $$aShipping list no.: 99-0104-P.
000218217 500__ $$a"December 1998."
000218217 500__ $$a"Committee print 105-W."
000218217 61010 $$aUnited States.$$bFood and Drug Administration$$xManagement.
000218217 650_0 $$aAccounting$$xLaw and legislation$$zUnited States.
000218217 650_0 $$aFinance, Public$$zUnited States.
000218217 85230 $$bdfich$$hY 4.C 73/8:$$i105-W
000218217 909CO $$ooai:library.usi.edu:218217$$pGLOBAL_SET
000218217 980__ $$aBIB
000218217 980__ $$aGOV RESOURCE
000218217 994__ $$aE0$$bISE